At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 329 enrolled
Drug / intervention
4 mL injection of Ampion +3 morebiological
Likely dose
4 mL injection of Ampionfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of Two Doses of Intra-Articular Injection of Ampion™ in Adults With Pain Due to Osteoarthritis of the Knee
In Brief
A Phase 2 clinical trial evaluating 4 mL injection of Ampion, 10 mL Injection of Ampion, and 2 other interventions for Osteoarthritis of the Knee. Completed, enrolled 329 participants.
Detailed Summary
This study will evaluate the efficacy of two doses of Intra-Articular Injection of Ampion™ in Adults with pain due to osteoarthritis of the knee.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis of the Knee
Countries--
Collaborators--
Timeline
Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2013
First PostedApr 2013
Primary CompletionAug 2013
Study CompletionOct 2013
TodayJul 2026
First PostedApr 24, 2013
Enrollment StartMar 29, 2013
Primary CompletionAug 19, 2013
Study CompletionOct 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 13.2 years ago
Interventions
4 mL injection of Ampionbiological
4 mL Injection of Ampion
10 mL Injection of Ampionbiological
10 mL Injection of Ampion
4 mL Injection of Placebodrug
4 mL Injection of Placebo
10 mL Injection of Placebodrug
10 mL Injection of Placebo